key: cord-0968864-zdhwn2nb
authors: Rhee, Chanu; Kanjilal, Sanjat; Baker, Meghan; Klompas, Michael
title: Reply to Cimolai: Even With Variable Viral Culture Methods, Culturing SARS-CoV-2 After 10 Days Appears to be Rare and Has Unclear Implications for Transmission
date: 2020-10-26
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1634
sha: 6f9d1f0ddc33bd1576dc3ef4cf5ab5c54401c64b
doc_id: 968864
cord_uid: zdhwn2nb

nan

M a n u s c r i p t 2 Dear Editor:

We thank Dr. Cimolai for his interest in our article and his thoughtful comments. [1] We appreciate his point about the variability in approaches to culturing SARS-CoV-2 and completely agree there is a need for more uniform methodology to determine the duration of infectivity for individuals with SARS-CoV-2 infection.

We are also grateful for the additional references that have demonstrated the potential for infectivity beyond 10 days from symptom onset. However, we believe it is telling that even with variable culturing methods, isolation of replication-competent virus after 10 days appears to be the exception rather than the rule. We further note that CDC's recommendation of 10 days of isolation is directed at immunocompetent patients with mild-moderate illness; CDC recommends up to 20 days for patients with severe or critical illness, or those who are severely immunocompromised, based on evidence of prolonged infectious shedding in those populations. [2, 3] It is also important to emphasize that CDC's criteria for discontinuation of isolation is also contingent on resolution of fever and improvement in symptoms. In some cases this can take more than 10 or even 20 days. [4] Furthermore, while it is clear that some individuals can have replicationcompetent virus cultured after 10 days, the human infectious dose is unknown and current data provide little insight into the degree of infectivity for those outliers.

Virologic and epidemiologic data indicate that infected individuals are generally most contagious around the time of symptom onset when their viral loads are highest, with a rapid decline in infectivity that parallels a steady drop in viral load in the ensuing

week. [5] In a Taiwanese prospective cohort of 100 individuals with COVID-19, all A c c e p t e d M a n u s c r i p t 3 secondary transmissions occurred with exposures within 5 days of symptom onset, and none when exposures occurred after 5 days. [6] It is therefore reasonable to assume that even in the rare cases where SARS-CoV-2 can be cultured beyond 10 days, the risk of transmission is likely low at that point, particularly if the individual is no longer symptomatic and coughing. Any residual risk of transmission is likely to be further be reduced if usual mitigation measures are followed. Indeed, CDC recommends that all people, including those who have had COVID-19, take steps to prevent the spread of infection, including hand hygiene, physical distancing, and wearing masks. [2] Ultimately, as CDC acknowledges, it is extremely difficult to establish recommendations that ensure that 100% of persons who are shedding replicationcompetent virus remain isolated. The risk of propagating transmission must be weighed against the potential detriments of highly conservative protocols. Prolonged isolation in healthcare settings, for example, contributes to delays in procedures and medical care, consumes personal protective equipment, imposes limitations on visitors, and can impede hospital discharge. Prolonged isolation outside of healthcare settings may have important psychosocial effects and impacts on the workforce. We look forward to additional studies that use standardized methods for culturing replicationcompetent virus and ideally pair this with epidemiologic data to inform better recommendations on the duration of isolation for individuals with SARS-COV-2 infection.

A c c e p t e d M a n u s c r i p t

report grants from Centers for Disease Control and Prevention during the conduct of the study, and personal fees from UpToDate, outside the submitted work

Not All Viral Culture Approaches Are Equal

Prevention: Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings

Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a

Multistate Health Care Systems Network -United States

Temporal dynamics in viral shedding and transmissibility of COVID-19

Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

A c c e p t e d M a n u s c r i p t 5